Table 1. . A comparison of outcome measures at baseline and 1-year follow-up for patients with Modic changes type 1 in the Albert and Bråten trials.

	Albert et al., Modic type 1, n = 162†					Bråten et al., Modic type 1, n = 118‡
	Baseline		1 year			Baseline		1 year			[29,30]
	Placebo	Antibiotic	Placebo	Antibiotic	p-value	Placebo	Antibiotic	Placebo	Antibiotic	p-value
RMDQ score	15.0 (12;18)	15.0 (11;18)	14.0 (11;18)	7 (4;11)	0.0001	12.3 (3.7)	12.9 (4.3)	10.3 (5.4)	8.2 (6.0)	0.02
LBP score	6.3 (4.7;8)	6.7 (5.3;7.0)	6.3 (4;7.7)	3.7 (1.3;5:8)	0.0004	6.3 (1.3)	6.5 (1.1)	5.2 (2.2)	4.5 (2.5)	0.06
EQ-5D score	60 (40;75)	59 (40;70)	60 (40;75)	75 (54;90)	0.0014	56 (0.16)	55 (0.18)	60 (0.21)	66 (0.21)	0.03

^†Values are presented as median and lower; upper quartiles.

^‡Values presented as mean and standard deviations.

EQ-5D: EuroQol- 5 Dimension; LBP: Lower back pain; RMDQ: Roland–Morris Disability Questionnaire.